认知障碍的中医康复评估体系构建

注册号:

Registration number:

ChiCTR2200063827 

最近更新日期:

Date of Last Refreshed on:

2023-04-15 22:04:04 

注册时间:

Date of Registration:

2022-09-18 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

认知障碍的中医康复评估体系构建

Public title:

Cognitive impairment traditional Chinese medicine rehabilitation assessment system building

注册题目简写:

English Acronym:

研究课题的正式科学名称:

老年认知功能障碍的中医康复体系构建与评价研究

Scientific title:

Traditional Chinese Medicine rehabilitation framework construction and assessment research for cognitive impairment in the elderly

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiMCTR2200006614

申请注册联系人:

刘宝虎 

研究负责人:

吴东宇 

Applicant:

Baohu Liu 

Study leader:

Dongyu Wu 

申请注册联系人电话:

Applicant telephone:

+86 18210826290

研究负责人电话:

Study leader's
telephone:

+86 13911202927

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

liubaohu2006@163.com

研究负责人电子邮件:

Study leader's E-mail:

wudongyu73@hotmail.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市朝阳区中环南路6号

研究负责人通讯地址:

北京市朝阳区中环南路6号

Applicant address:

6 Zhonghuan South Road, Chaoyang District, Beijing

Study leader's address:

6 Zhonghuan South Road, Chaoyang District, Beijing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中医科学院望京医院

Applicant's institution:

Wangjing Hospital, China Academy of Chinese Medical Sciences

研究负责人所在单位:

中医科学院望京医院

Affiliation of the Leader:

Wangjing Hospital, China Academy of Chinese Medical Sciences

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

CI2021A01410

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国中医科学院望京医院伦理委员会

Name of the ethic committee:

Wangjing Hospital, China Academy of Chinese Medical Sciences ethics committee

伦理委员会批准日期:

Date of approved by ethic committee:

2022-07-19 00:00:00

伦理委员会联系人:

王浩

Contact Name of the ethic committee:

Hao Wang

伦理委员会联系地址:

北京市朝阳区中环南路6号

Contact Address of the ethic committee:

6 Zhonghuan South Road, Chaoyang District, Beijing

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

中国中医科学院望京医院

Primary sponsor:

Wangjing Hospital, China Academy of Chinese Medical Sciences

研究实施负责(组长)单位地址:

北京市朝阳区中环南路6号

Primary sponsor's address:

6 Zhonghuan South Road, Chaoyang District, Beijing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

中国中医科学院望京医院

具体地址:

北京市朝阳区中环南路6号

Institution
hospital:

Wangjing Hospital, China Academy of Chinese Medical Sciences

Address:

6 Zhonghuan South Road, Chaoyang District, Beijing

经费或物资来源:

中国中医科学院科技创新工程项目

Source(s) of funding:

Scientific and technological innovation project of China Academy of Chinese Medical Sciences

研究疾病:

老年性痴呆、血管性痴呆  

Target disease:

Alzheimer disease,Vascular dementia

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

构建认知障碍中医康复评估体系  

Objectives of Study:

Cognitive impairment traditional Chinese medicine rehabilitation assessment system building

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.有其他脑部器质性疾病、抑郁症及精神病;
2.由其他因素引起的认知障碍或痴呆,如脑外伤、帕金森病等;
3.不能配合检查的患者(如中医四诊仪、经络检测仪及神经电生理评估等)。

Exclusion criteria:

1. Other organic brain diseases, depression, and mental illness;
2. Cognitive impairment or dementia caused by other factors, such as brain injury, Parkinson's disease, etc;
3. Patients who cannot cooperate with the examination (such as traditional Chinese medicine four diagnostic instruments, meridian detectors, and neuroelectrophysiological assessments).

研究实施时间:

Study execute time:

From 2021-11-01 00:00:00 To 2024-11-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-09-15 00:00:00 To 2024-11-01 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

120

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

中国中医科学院望京医院 

单位级别:

三甲 

Institution
hospital:

Wangjing Hospital, China Academy of Chinese Medical Sciences

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

脑电图

指标类型:

主要指标

Outcome:

electroencephalogram

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

诱发电位

指标类型:

主要指标

Outcome:

event-related potential

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

简易精神状态量表

指标类型:

主要指标

Outcome:

Mini-mental state examination

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血管性痴呆认知评估量表

指标类型:

主要指标

Outcome:

Vascular dementia assessment scale-cog

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

日常生活能力量表

指标类型:

主要指标

Outcome:

Activity of Daily Living Scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血管性痴呆中医辨证量表

指标类型:

主要指标

Outcome:

Traditional Chinese Medicine Syndrome Differentiation Scale for Vascular Dementia

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

阿尔茨海默评定量表-认知项目

指标类型:

主要指标

Outcome:

Alzheimer’s Disease Assessment Scale-Cognitive section

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血管性痴呆中医辨证量表

指标类型:

主要指标

Outcome:

The scale for the differentiation of syndromes of vascular dementia

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

痴呆证候要素量表

指标类型:

主要指标

Outcome:

The Pattern Element Scale for Dementia

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 60 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

not public

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病历记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-09-18 22:35:34